Valvular & structural heart diseaseCohort study

Liver-related outcomes in patients with tricuspid regurgitation

Eur J Heart FailPublished

  • Retrospective cohort study

Authors' conclusion

Significant TR is associated with incident cirrhosis, with risk varying by aetiology. The development of cirrhosis portends a worse survival

Study context

Population
Adults with documented tricuspid regurgitation (TR) severity without prevalent liver disease, 2004–20227,226 (17.3%) ≥moderate TR
Participants
41,950 adults
Exposure
TR severity and liver-related outcomes
Outcome
Liver-related outcomes: cirrhosis, hepatocellular carcinoma (HCC) and liver-related death
Follow-up
Median 6.4 years

Main finding

As reported in the abstract

Incidence in ≥moderate TR (per 1000 person-years)

Cirrhosis incidence, ≥moderate TR

4.54 (95% CI 3.89-5.29) per 1000 person-years

Hepatocellular carcinoma (HCC) incidence, ≥moderate TR

1.25 (95% CI 0.92-1.68) per 1000 person-years

Liver-related death incidence, ≥moderate TR

1.33 (95% CI 0.99-1.77) per 1000 person-years

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Cirrhosis by TR aetiology (≥moderate TR) — Ventricular TR vs Atrial TR2.33 (1.22–4.43)P = 0.009
Cirrhosis by TR aetiology (≥moderate TR) — Lead-associated TR vs Atrial TR2.66 (1.16–6.09)P = 0.02

Predictors of cirrhosis in ≥moderate TR

Independent predictors: HFpEF, RV dysfunction, cholestatic liver injury

Survival impact of incident cirrhosis (≥moderate TR)

Incident cirrhosis increased all-cause and CV death risks

Original publication

Liver-related outcomes in patients with tricuspid regurgitation. Eur J Heart Fail. Published 24 March 2026. doi:10.1093/ejhf/xuag057

Summarised from the published abstract; every number is checked against it